World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
67
Citations
13705
World Ranking
8338
National Ranking
3761

Edward P. Acosta publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Edward P. Acosta sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 257 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Edward P. Acosta D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Edward P. Acosta sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 67 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Edward P. Acosta is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, pulmonary and respiratory medicine, virology, molecular biology, and pediatrics, perinatology, and child health.

The scientist's work covers a range of topics including:

  • HIV/AIDS drug development and treatment
  • HIV research and treatment
  • HIV/AIDS research and interventions
  • HIV-related health complications and treatments
  • Cystic fibrosis research advances
  • Pharmacological effects and toxicity studies
  • Cytomegalovirus and herpesvirus research

The following are some of the recent papers by Edward P. Acosta:

  • Impact of lipid nanoparticle size on mRNA vaccine immunogenicity, 2021, Journal of Controlled Release
  • Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNA, 2021, Advanced Functional Materials
  • Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies, 2021, Clinical Infectious Diseases
  • Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial, 2020, BMJ Open
  • HIV post-treatment controllers have distinct immunological and virological features, 2023, Proceedings of the National Academy of Sciences

Frequent co-authors collaborating with Edward P. Acosta include:

  • Kevin J. Ryan
  • Jennifer S. Guimbellot
  • Ellen Townley
  • David W. Kimberlin
  • Evgenia Aga

Edward P. Acosta's research has been published repeatedly in several venues, among the most frequent are:

  • UNC Libraries
  • The Journal of Infectious Diseases
  • Journal of Cystic Fibrosis
  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • American Journal of Respiratory and Critical Care Medicine

Best Publications

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    D. W. Kimberlin;P. M. Jester;P. J. Sánchez;A. Ahmed

  • Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney

  • Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

    Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten

  • Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

    David R Bangsberg;Edward P Acosta;Reena Gupta;David Guzman

  • Dose-response Curve Slope Sets Class-Specific Limits on Inhibitory Potential of Anti-HIV Drugs

    Lin Shen;Susan Peterson;Ahmad R Sedaghat;Moira A McMahon

  • Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease

    David W Kimberlin;Edward P Acosta;Pablo J Sánchez;Sunil Sood

  • Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals

    David B. Clifford;Scott Evans;Yijun Yang;Edward P. Acosta

  • Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Christina Lalama

  • Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy

    D. McMahon;J. Jones;A. Wiegand;S. J. Gange

  • Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

    Heather J. Ribaudo;David W. Haas;Camlin Tierney;Richard B. Kim

  • Indinavir concentrations and antiviral effect.

    Edward P. Acosta;Keith Henry;Leslie Baken;Linda M. Page

  • Preexisting Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz-Based Regimen in Treatment-Naive HIV-1–Infected Subjects

    Daniel R Kuritzkes;Christina M Lalama;Heather J Ribaudo;Michelle Marcial

  • Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

    Ronald J Bosch;Justin Ritz;Jason M Hataye

  • Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21 WAF1/CIP1 and p27 KIP1 pathway

    Santosh Kumar Singh;Saswati Banerjee;Edward P. Acosta;James W. Lillard

  • Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).

    Babafemi Taiwo;Lu Zheng;Sebastien Gallien;Roy M. Matining

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Golnaz Namazi;Jesse M Fajnzylber;Evgenia Aga;Ronald J Bosch

  • Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia

    Jeffrey S. A. Stringer;Moses Sinkala;Moses Sinkala;Moses Sinkala;Courtney C. Maclean;Jens Levy;Jens Levy

  • Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

    Heather J. Ribaudo;Huan Liu;Matthias Schwab;Elke Schaeffeler

  • Gender differences in human pharmacokinetics and pharmacodynamics.

    Courtney V. Fletcher;Edward P. Acosta;Edward P. Acosta;Jill M. Strykowski;Jill M. Strykowski

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    David W. Kimberlin;Penelope M. Jester;Pablo J. Sánchez;Amina Ahmed

Frequent Co-Authors

Roy M. Gulick
Roy M. Gulick Cornell University
David W. Haas
David W. Haas Vanderbilt University Medical Center
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Andrew Wiznia
Andrew Wiznia Albert Einstein College of Medicine
David W. Kimberlin
David W. Kimberlin University of Alabama at Birmingham
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Sten H. Vermund
Sten H. Vermund Yale University
Robert L. Goldenberg
Robert L. Goldenberg Columbia University
Keith Henry
Keith Henry Hennepin County Medical Center
Richard J. Whitley
Richard J. Whitley University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens the door to a wide range of rewarding online degree programs and career options in healthcare and life sciences. Many students interested in these fields consider programs that expand their qualifications or help them transition into new roles within health and science sectors.

For those with a nursing background, enrolling in the easiest rn to bsn program can lead to greater clinical opportunities and advancement. Others looking to move into management roles often pursue the fastest online master's in healthcare management for a quick pathway to leadership positions.

If mental health is your passion, specialized degrees like psychiatric np programs offer focused training and faster entry into high-demand roles. Additionally, for those interested in dietetics and wellness, pursuing an accelerated nutrition degree online can rapidly prepare you for careers in nutritional science and public health.

These flexible online programs make it easier for students and professionals in Biology and Biochemistry to find pathways tailored to their personal interests and career ambitions.

Best Scientists Citing Edward P. Acosta

Trending Scientists

Recently Published Articles